FDA accepts filing of Leqembi ® (lecanemab-irmb) sBLA for IV maintenance dosing for the treatment of early Alzheimer’s Disease

Post Content Read More

Please follow and like us:

Leave a Reply

Your email address will not be published. Required fields are marked *